These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37079980)

  • 1. Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
    Keller K; Kohring C; Farmakis IT; Valerio L; Barco S; Bätzing J; Akmatov MK; Konstantinides S; Münzel T; Hobohm L; Holstiege J
    Thromb Res; 2023 Jun; 226():9-17. PubMed ID: 37079980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
    Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
    Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
    J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
    Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.
    Lutsey PL; Evensen LH; Thenappan T; Prins KW; Walker RF; Farley JF; MacLehose RF; Alonso A; Zakai NA
    J Am Heart Assoc; 2022 Jul; 11(14):e024358. PubMed ID: 35861839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Venous Thromboembolism After Achilles Tendon Rupture: A Nationwide Danish Cohort Study of 28,546 Patients With Achilles Tendon Rupture.
    Pedersen MH; Wahlsten LR; Grønborg H; Gislason GH; Petersen MM; Bonde AN
    Am J Sports Med; 2019 Nov; 47(13):3229-3237. PubMed ID: 31574237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
    Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
    Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
    Yhim HY; Lee J; Kim KH; Kim SA; Lee JY; Hwang HG; Hong J; Lee JO; Bang SM
    Thromb Res; 2023 Nov; 231():50-57. PubMed ID: 37804738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between migraine and risk of venous thromboembolism: A nationwide cohort study.
    Peng KP; Chen YT; Fuh JL; Tang CH; Wang SJ
    Headache; 2016 Sep; 56(8):1290-9. PubMed ID: 27411732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimating the incidence of venous thromboembolism (VTE) using various types of routine data of the German healthcare system].
    Ohlmeier C; Leverkus F; Kloss S; Basic E; Bleß HH
    Z Evid Fortbild Qual Gesundhwes; 2018 Dec; 139():46-52. PubMed ID: 30477975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
    Grilz E; Posch F; Nopp S; Königsbrügge O; Lang IM; Klimek P; Thurner S; Pabinger I; Ay C
    Eur Heart J; 2021 Jun; 42(23):2299-2307. PubMed ID: 33769475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study.
    Gouverneur A; Avouac J; Prati C; Cracowski JL; Schaeverbeke T; Pariente A; Truchetet ME
    Eur J Clin Pharmacol; 2022 Dec; 78(12):1981-1990. PubMed ID: 36284012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
    Keller K; Sivanathan V; Schmitt VH; Ostad MA; Münzel T; Espinola-Klein C; Hobohm L
    Thromb Res; 2022 Nov; 219():77-85. PubMed ID: 36137330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism.
    Reed S; Koro C; DiBello J; Becker K; Bauerfeind A; Franke C; Heinemann K
    Eur J Contracept Reprod Health Care; 2021 Dec; 26(6):439-446. PubMed ID: 34644228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide family study of venous thromboembolism and risk of arterial vascular disease.
    Zöller B; Li X; Sundquist J; Sundquist K
    Heart; 2016 Aug; 102(16):1315-21. PubMed ID: 27048773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
    Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
    Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
    Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
    Ekstrand C; Linder M; Baricault B; Lafaurie M; Sailler L; Lapeyre-Mestre M; Kieler H; Moulis G; Bahmanyar S
    Thromb Res; 2019 Jun; 178():124-131. PubMed ID: 31026663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.